MedVellum
MedVellum
Back to Library
Paediatrics
Rheumatology
Nephrology

Henoch-Schönlein Purpura (IgA Vasculitis)

High EvidenceUpdated: 2025-12-24

On This Page

Red Flags

  • Intussusception (Severe Abdominal Pain, Bloody Stool)
  • Renal Involvement (Haematuria, Proteinuria, Nephritic/Nephrotic Syndrome)
  • Scrotal Pain (Testicular involvement)
  • Severe GI Haemorrhage
Overview

Henoch-Schönlein Purpura (IgA Vasculitis)

1. Clinical Overview

Summary

Henoch-Schönlein Purpura (HSP), now formally known as IgA Vasculitis (IgAV), is the most common vasculitis in children. It is a small vessel vasculitis characterised by IgA-dominant immune complex deposition. The classic presentation is a tetrad of features: Purpura (palpable, non-thrombocytopenic), Arthritis/Arthralgia, Abdominal Pain, and Renal Involvement. It typically occurs in children aged 3-10 years, often following an upper respiratory tract infection. The condition is usually self-limiting within 4-6 weeks, but renal involvement (HSP Nephritis = IgA Nephropathy) can lead to long-term morbidity and requires monitoring. Supportive care is the mainstay; steroids may be used for severe abdominal or joint symptoms. Long-term urinalysis and BP monitoring for at least 6-12 months is essential. [1,2]

Clinical Pearls

Palpable Purpura = Vasculitis: The rash is palpable (raised) because it is due to vessel inflammation, not just bleeding. Non-blanching.

"Buttocks and Legs": Rash is characteristically on lower limbs and buttocks (gravity-dependent areas). This distribution is classic.

Renal Surveillance is Key: Most children recover fully, but ~1-2% develop significant renal disease. Monitor urinalysis and BP for 6-12 months.

Watch for Intussusception: Severe abdominal pain in HSP may indicate intussusception (ileocolic involvement). Requires USS/Surgery.


2. Epidemiology

Demographics

  • Age: Peak 4-7 years. 90% of cases in children less than 10 years.
  • Sex: Male > Female (2:1).
  • Seasonality: More common in Winter/Spring (follows URTI season).

Incidence

  • Most common childhood systemic vasculitis.
  • Incidence: ~10-20 per 100,000 children per year.

Triggers

  • Upper Respiratory Tract Infection (URTI): Most common trigger. Streptococcal, Viral (EBV, Varicella).
  • Medications: Rare trigger.
  • Vaccinations: Rarely associated.

3. Pathophysiology

Mechanism

  1. Trigger (Often URTI): Infection stimulates immune response.
  2. IgA Production: Excessive or abnormal IgA1 production.
  3. Immune Complex Formation: IgA-containing immune complexes form.
  4. Deposition in Small Vessels: Complexes deposit in walls of small vessels (Skin, Joints, GI tract, Kidneys).
  5. Inflammation (Small Vessel Vasculitis): Complement activation and neutrophil infiltration → Vessel wall damage → Leukocytoclasis.
  6. Clinical Manifestations: Purpura (skin vessels), Arthritis (joint vessels), Abdominal pain (GI vessels), Nephritis (Glomeruli – IgA Nephropathy pattern).

Histopathology

  • Skin Biopsy: Leukocytoclastic vasculitis. IgA deposition on immunofluorescence.
  • Renal Biopsy (If Done): Mesangial proliferative glomerulonephritis. Mesangial IgA deposits. (Identical to Primary IgA Nephropathy).

4. Differential Diagnosis
ConditionKey Features
Henoch-Schönlein Purpura (IgA Vasculitis)Child. Palpable purpura (buttocks/legs). Arthralgia. Abdominal pain. Haematuria. Normal platelets.
Meningococcal SepticaemiaRapidly evolving non-blanching rash. Unwell child. Shock. Petechiae progressing to purpura fulminans. EMERGENCY.
ITP (Immune Thrombocytopenic Purpura)Non-palpable petechiae/bruising. Low Platelets. No systemic symptoms.
Child Abuse (NAI)Bruising in unusual locations. Pattern injuries. Safeguarding concern.
Hypersensitivity VasculitisDrug reaction. May have similar rash. History of drug exposure.
Acute Post-Streptococcal GlomerulonephritisGross haematuria, Oedema, Hypertension. Follows Strep infection. Low C3. No purpura.
Kawasaki DiseaseFever ≥5 days, Conjunctivitis, Rash (not typically purpuric), Mucosal changes, Extremity changes. CREAM criteria.

5. Clinical Presentation (The Classic Tetrad)

1. Skin: Palpable Purpura (100%)

  • Appearance: Non-blanching, palpable (raised) rash. Petechiae, Purpura, Ecchymoses.
  • Distribution: Buttocks and Extensor surfaces of lower limbs (Gravity-dependent). May also involve upper limbs. Spares trunk usually.
  • Evolution: May start as urticarial lesions before becoming purpuric.
  • Key Feature: Palpable – distinguishes from ITP/other non-vasculitic purpura.

2. Joints: Arthritis/Arthralgia (~75%)

  • Joints Affected: Large joints – Knees, Ankles. Sometimes Wrists, Elbows.
  • Features: Pain, Swelling, Limitation of movement. Periarticular. Migratory.
  • Transient: Resolves without permanent damage. Non-erosive.

3. Gastrointestinal (~50-70%)

  • Abdominal Pain: Colicky. Central.
  • Cause: Vasculitis of GI tract wall → Oedema, Haemorrhage, Ischaemia.
  • Complications:
    • GI Bleeding: Occult blood, Melaena, Haematemesis.
    • Intussusception: Ileocolic most common. Bowel wall oedema acts as lead point. RED FLAG – Requires urgent USS, ± Surgical reduction.
    • Bowel Infarction / Perforation: Rare but serious.

4. Renal (~30-50%)

  • Spectrum: Microscopic haematuria → Proteinuria → Nephritic Syndrome → Nephrotic Syndrome → Rapidly Progressive GN (Rare).
  • Timing: May occur at presentation or develop weeks to months later.
  • Significance: Main determinant of long-term morbidity. ~1-2% develop chronic kidney disease.
  • Histology (if Biopsy): IgA Nephropathy (Mesangial IgA deposition).

5. Other Systems

SystemFeatures
Scrotal / TesticularScrotal oedema, Orchitis. Can mimic Testicular Torsion.
CNS (Rare)Headache, Seizures, Altered consciousness.
Pulmonary (Rare)Pulmonary haemorrhage.

6. Investigations

Diagnosis is Clinical (No Specific Test)

  • Platelet Count: NORMAL – Excludes ITP.
  • FBC: Usually normal. May have mild leucocytosis, raised ESR.
  • Renal Function: U&E, Creatinine – Usually normal unless significant nephritis.
  • Urinalysis: Essential. Check for Haematuria, Proteinuria. Urine PCR if protein detected.
  • Serum IgA: May be elevated (~50%), but not diagnostic.
  • C3/C4 (Complement): Normal (Distinguishes from PSGN where C3 is low).
  • ASOT / Anti-DNase B: May be elevated if recent Strep infection (trigger), but not specific.
  • Stool: Occult blood if GI involvement suspected.
  • Skin Biopsy: Rarely needed. Shows Leukocytoclastic Vasculitis + IgA on IF.
  • USS Abdomen: If intussusception suspected (Target sign).

7. Management

Management Algorithm

       CHILD WITH PALPABLE PURPURA
       + Arthralgia / Abdominal Pain / Haematuria
                     ↓
       DIAGNOSIS: HENOCH-SCHÖNLEIN PURPURA (IgA Vasculitis)
       (Clinical Diagnosis – No specific test)
    ┌──────────────────────────────────────────────┐
    │  CHECK:                                      │
    │  - Platelet Count (NORMAL rules out ITP)    │
    │  - Urinalysis (Haematuria, Proteinuria)     │
    │  - BP                                        │
    │  - Renal Function (U&E)                      │
    └──────────────────────────────────────────────┘
                     ↓
       ASSESS FOR SEVERE COMPLICATIONS
       (Intussusception, Renal Insufficiency, GI Bleed)
    ┌────────────────┴────────────────┐
 COMPLICATED                     UNCOMPLICATED
    ↓                                 ↓
 ADMIT / INVESTIGATE             SUPPORTIVE CARE
 (See Below)                     (Outpatient)
                     ↓
       SUPPORTIVE MANAGEMENT (Majority)
    ┌──────────────────────────────────────────────┐
    │  - Analgesia: Paracetamol. NSAIDs (if no     │
    │    renal/GI concerns) for joint pain.        │
    │  - Hydration                                 │
    │  - Rest                                      │
    │  - Most resolve in 4-6 weeks.                │
    └──────────────────────────────────────────────┘
                     ↓
       STEROIDS (Considered for)
    ┌──────────────────────────────────────────────┐
    │  - Severe Abdominal Pain (May reduce duration│
    │    and risk of intussusception - debated)    │
    │  - Severe Arthritis                          │
    │  - Scrotal Oedema                            │
    │  - Prednisolone 1-2mg/kg/day for 1-2 weeks,  │
    │    then taper.                               │
    │  (Steroids do NOT prevent renal disease)     │
    └──────────────────────────────────────────────┘
                     ↓
       RENAL INVOLVEMENT?
    ┌────────────────┴────────────────┐
 YES (Significant Proteinuria,       NO
  Nephritic/Nephrotic Syndrome,
  Renal Impairment)
    ↓                                 ↓
 REFER PAEDIATRIC            MONITOR URINALYSIS
 NEPHROLOGY                  + BP
 - Consider Renal Biopsy     Weekly initially,
 - ACEi for Proteinuria      then monthly for
 - Steroids +/- Immuno-      6-12 months
   suppression for
   Severe Nephritis

Supportive Care

  • Hydration, Rest, Analgesia.
  • Paracetamol: First-line for pain.
  • NSAIDs: For significant joint pain. Avoid if significant renal or GI involvement.

Corticosteroids

  • Indication: Severe abdominal pain, Severe arthritis, Scrotal involvement.
  • Dose: Prednisolone 1-2 mg/kg/day (Max 60mg) for 1-2 weeks, tapered.
  • Note: Steroids may shorten duration of abdominal/joint symptoms but do NOT prevent or treat nephritis.

Renal Involvement

  • Regular Urinalysis + BP Monitoring: Weekly initially, then monthly for 6-12 months.
  • ACE Inhibitor: If persistent proteinuria.
  • Nephrology Referral: If significant proteinuria (PCR >100), Nephritic/Nephrotic syndrome, Renal impairment.
  • Renal Biopsy: If severe nephritis to guide immunosuppression.
  • Immunosuppression (Severe Nephritis): Steroids, Cyclophosphamide, MMF (Specialist decision).

8. Complications
ComplicationNotes
HSP NephritisMost important long-term complication. ~30-50% have some renal involvement. ~1-2% develop CKD.
Intussusception~2-3%. Usually Ileocolic. Bowel wall oedema acts as lead point. USS + Reduction.
GI HaemorrhageUsually mild. Severe haemorrhage is rare.
Bowel Infarction / PerforationRare.
Recurrence~30% relapse, usually milder. Often within first 3 months.

9. Prognosis and Outcomes
  • Most Children Recover Fully: 90-95% without long-term sequelae.
  • Self-Limiting: Usually resolves in 4-6 weeks.
  • Renal Long-Term: ~1-2% develop significant CKD. Risk factors: Severe initial nephritis, Older age, Nephrotic-range proteinuria.
  • Recurrence: ~30%, usually within 3 months. Relapses are typically milder.

10. Evidence and Guidelines

Key Guidelines

GuidelineOrganisationKey Recommendations
IgA Vasculitis (HSP) ManagementACR/EULAR (SHARE Initiative)Supportive care. Steroids for severe symptoms. Renal monitoring.
NICE CKSNICEUrinalysis monitoring for 6-12 months.

11. Patient and Layperson Explanation

What is Henoch-Schönlein Purpura?

HSP is a condition where the small blood vessels become inflamed. This causes a characteristic rash (purplish spots on the legs and bottom) and can also affect the joints (causing pain), the tummy (causing cramps), and the kidneys.

Why did my child get it?

We don't know exactly, but it often happens after a viral or bacterial infection (like a cold or sore throat). The immune system overreacts and attacks the blood vessel walls.

Is it serious?

Usually not. Most children recover completely within a few weeks. However, we need to monitor the urine and blood pressure for several months to check the kidneys are not affected.

What is the treatment?

Usually just rest and pain relief. Sometimes we use a short course of steroids if the tummy pain or joint pain is severe. The most important thing is to check the urine regularly to make sure the kidneys are OK.


12. References

Primary Sources

  1. Ozen S, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936-41. PMID: 16322081.
  2. Trnka P. Henoch-Schönlein purpura in children. J Paediatr Child Health. 2013;49(12):995-1003. PMID: 24134426.

13. Examination Focus

Common Exam Questions

  1. Classic Tetrad: "What are the four main features of HSP?"
    • Answer: Palpable Purpura, Arthritis/Arthralgia, Abdominal Pain, Renal Involvement (Haematuria/Proteinuria).
  2. Rash Distribution: "Where is the rash typically located in HSP?"
    • Answer: Buttocks and Extensor surfaces of Lower Limbs (Gravity-dependent).
  3. Key Investigation: "How do you distinguish HSP from ITP?"
    • Answer: Platelet count. HSP = Normal Platelets. ITP = Low Platelets.
  4. Long-Term Complication: "What is the main determinant of long-term morbidity in HSP?"
    • Answer: Renal Involvement (HSP Nephritis / IgA Nephropathy). Requires monitoring.

Viva Points

  • Intussusception in HSP: Explain mechanism (Bowel wall oedema as lead point).
  • Renal Monitoring Duration: Urinalysis and BP for 6-12 months.

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists.

Last updated: 2025-12-24

At a Glance

EvidenceHigh
Last Updated2025-12-24

Red Flags

  • Intussusception (Severe Abdominal Pain, Bloody Stool)
  • Renal Involvement (Haematuria, Proteinuria, Nephritic/Nephrotic Syndrome)
  • Scrotal Pain (Testicular involvement)
  • Severe GI Haemorrhage

Clinical Pearls

  • **Palpable Purpura = Vasculitis**: The rash is palpable (raised) because it is due to vessel inflammation, not just bleeding. Non-blanching.
  • **"Buttocks and Legs"**: Rash is characteristically on lower limbs and buttocks (gravity-dependent areas). This distribution is classic.
  • **Renal Surveillance is Key**: Most children recover fully, but ~1-2% develop significant renal disease. Monitor urinalysis and BP for 6-12 months.
  • **Watch for Intussusception**: Severe abdominal pain in HSP may indicate intussusception (ileocolic involvement). Requires USS/Surgery.

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines